These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26252149)

  • 21. Biotech in Bangalore.
    Russo G
    Nature; 2008 Apr; 452(7187):660-1. PubMed ID: 18389533
    [No Abstract]   [Full Text] [Related]  

  • 22. Italian biotech too reliant on big pharma.
    Meldolesi A
    Nat Biotechnol; 2004 Aug; 22(8):1047. PubMed ID: 15309759
    [No Abstract]   [Full Text] [Related]  

  • 23. Malaysia seeks biotech partners.
    Aldridge S
    Nat Biotechnol; 2009 Apr; 27(4):305. PubMed ID: 19352354
    [No Abstract]   [Full Text] [Related]  

  • 24. Can China's supply of scientific talent keep up with demand?
    Wong G
    Nat Biotechnol; 2008 Feb; 26(2):243-4. PubMed ID: 18259182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hatteras rounds up $90 million to lead biotech rebound in North Carolina.
    Erickson D
    Nat Biotechnol; 2015 Nov; 33(11):1121-2. PubMed ID: 26544128
    [No Abstract]   [Full Text] [Related]  

  • 26. How to sail smoothly from academia to industry.
    Powell K
    Nature; 2018 Mar; 555(7697):549-551. PubMed ID: 29565380
    [No Abstract]   [Full Text] [Related]  

  • 27. Joseph Miletich talks about big Pharma, biotech and the future of Amgen. Interview by Steve Carney.
    Miletich JP
    Drug Discov Today; 2006 Mar; 11(5-6):188-90. PubMed ID: 16580595
    [No Abstract]   [Full Text] [Related]  

  • 28. Ask the experts: how to get hired.
    Wong GH
    Nat Biotechnol; 2004 Nov; 22(11):1481-2. PubMed ID: 15529175
    [No Abstract]   [Full Text] [Related]  

  • 29. Biotech giant helps itself without swallowing Galapagos whole.
    Senior M
    Nat Biotechnol; 2019 Oct; 37(10):1104-1105. PubMed ID: 31578499
    [No Abstract]   [Full Text] [Related]  

  • 30. Fresh from the biotech pipeline--2015.
    Morrison C
    Nat Biotechnol; 2016 Feb; 34(2):129-32. PubMed ID: 26849511
    [No Abstract]   [Full Text] [Related]  

  • 31. Counterpoint: biotech needs more than DTC as usual.
    Mack J
    Nat Biotechnol; 2006 Mar; 24(3):267. PubMed ID: 16525380
    [No Abstract]   [Full Text] [Related]  

  • 32. Does biotech M&A benefit investors?
    Jacobs T
    Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
    [No Abstract]   [Full Text] [Related]  

  • 33. Masters of efficiency.
    Hoag H
    Nat Biotechnol; 2007 Jan; 25(1):139-40. PubMed ID: 17211408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Third-quarter biotech job picture.
    Francisco M
    Nat Biotechnol; 2015 Nov; 33(11):1211. PubMed ID: 26544148
    [No Abstract]   [Full Text] [Related]  

  • 35. Sanofi Aventis grooms its ranks for biotech partnering.
    Moran N
    Nat Biotechnol; 2009 Jul; 27(7):581-2. PubMed ID: 19587645
    [No Abstract]   [Full Text] [Related]  

  • 36. EC convenes crisis talks on European biotech sector.
    Jones D
    Nat Biotechnol; 2010 Feb; 28(2):110-1. PubMed ID: 20139930
    [No Abstract]   [Full Text] [Related]  

  • 37. GlaxoSmithKline pushes its labs towards 'biotech' future.
    Adam D
    Nature; 2001 Mar; 410(6824):5. PubMed ID: 11242002
    [No Abstract]   [Full Text] [Related]  

  • 38. Biotech boot camp.
    Ledford H
    Nature; 2015 Mar; 519(7544):402-5. PubMed ID: 25810186
    [No Abstract]   [Full Text] [Related]  

  • 39. Future of the Euroscientist.
    Collingham D
    Nature; 1994 Oct; 371(6499):724. PubMed ID: 7935821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translating science into business.
    Schuster S
    Nature; 2007 Mar; 446(7135):582. PubMed ID: 17421073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.